Figure 7. Cell viability results using MTS assay.
Cell viability curves comparing the drug response of (a) 4T1 breast cancer, (b) B16 melanoma cells with their Carboplatin-tolerant variants, and the drug response of (c) DU145 prostate cancer cells and Paclitaxel–resistant DU145 to Paclitaxel after 24 h of treatment. Error bars represent standard error of the mean (n=3).